Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study.

Crisafulli E, Ielpo A, Barbeta E, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Respir Res. 2018 Dec 27;19(1):261. doi: 10.1186/s12931-018-0951-4.

2.

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia.

Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.

Chest. 2018 Nov 22. pii: S0012-3692(18)32733-8. doi: 10.1016/j.chest.2018.11.006. [Epub ahead of print]

PMID:
30471269
3.

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.

Cillóniz C, Liapikou A, Martin-Loeches I, García-Vidal C, Gabarrús A, Ceccato A, Magdaleno D, Mensa J, Marco F, Torres A.

PLoS One. 2018 Jul 18;13(7):e0200504. doi: 10.1371/journal.pone.0200504. eCollection 2018.

4.

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis.

Crisafulli E, Guerrero M, Ielpo A, Ceccato A, Huerta A, Gabarrús A, Soler N, Chetta A, Torres A.

Sci Rep. 2018 Jun 18;8(1):9236. doi: 10.1038/s41598-018-27680-y.

5.

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.

Estirado C, Ceccato A, Guerrero M, Huerta A, Cilloniz C, Vilaró O, Gabarrús A, Gea J, Crisafulli E, Soler N, Torres A.

Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.

6.

Community-Acquired Legionella Pneumonia in Human Immunodeficiency Virus-Infected Adult Patients: A Matched Case-Control Study.

Cillóniz C, Miguel-Escuder L, Pedro-Bonet ML, Falcó V, Lopez Y, García-Vidal C, Gabarrús A, Moreno A, Torres A, Miró JM; Legionella-HIV Researchers .

Clin Infect Dis. 2018 Aug 31;67(6):958-961. doi: 10.1093/cid/ciy314.

PMID:
29659759
7.

Acute respiratory distress syndrome in mechanically ventilated patients with community-acquired pneumonia.

Cilloniz C, Ferrer M, Liapikou A, Garcia-Vidal C, Gabarrus A, Ceccato A, Puig de La Bellacasa J, Blasi F, Torres A.

Eur Respir J. 2018 Mar 29;51(3). pii: 1702215. doi: 10.1183/13993003.02215-2017. Print 2018 Mar.

PMID:
29545274
8.

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients.

Ferrer M, Travierso C, Cilloniz C, Gabarrus A, Ranzani OT, Polverino E, Liapikou A, Blasi F, Torres A.

PLoS One. 2018 Jan 25;13(1):e0191721. doi: 10.1371/journal.pone.0191721. eCollection 2018.

9.

Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.

Briel M, Spoorenberg SMC, Snijders D, Torres A, Fernandez-Serrano S, Meduri GU, Gabarrús A, Blum CA, Confalonieri M, Kasenda B, Siemieniuk RAC, Boersma W, Bos WJW, Christ-Crain M; Ovidius Study Group; Capisce Study Group; STEP Study Group.

Clin Infect Dis. 2018 Jan 18;66(3):346-354. doi: 10.1093/cid/cix801.

PMID:
29020323
10.

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality.

Bermejo-Martin JF, Cilloniz C, Mendez R, Almansa R, Gabarrus A, Ceccato A, Torres A, Menendez R; NEUMONAC group.

EBioMedicine. 2017 Oct;24:231-236. doi: 10.1016/j.ebiom.2017.09.023. Epub 2017 Sep 21.

11.

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia.

Cillóniz C, Ceccato A, de la Calle C, Gabarrús A, Garcia-Vidal C, Almela M, Soriano A, Martinez JA, Marco F, Vila J, Torres A.

PLoS One. 2017 Aug 7;12(8):e0182436. doi: 10.1371/journal.pone.0182436. eCollection 2017.

12.

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.

Ceccato A, Cilloniz C, Ranzani OT, Menendez R, Agusti C, Gabarrus A, Ferrer M, Sibila O, Niederman MS, Torres A.

PLoS One. 2017 Jun 15;12(6):e0178022. doi: 10.1371/journal.pone.0178022. eCollection 2017.

13.

New Sepsis Definition (Sepsis-3) and Community-acquired Pneumonia Mortality. A Validation and Clinical Decision-Making Study.

Ranzani OT, Prina E, Menéndez R, Ceccato A, Cilloniz C, Méndez R, Gabarrus A, Barbeta E, Bassi GL, Ferrer M, Torres A.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1287-1297. doi: 10.1164/rccm.201611-2262OC.

PMID:
28613918
14.

Comparison of two prognostic scores (BSI and FACED) in a Spanish cohort of adult patients with bronchiectasis and improvement of the FACED predictive capacity for exacerbations.

Rosales-Mayor E, Polverino E, Raguer L, Alcaraz V, Gabarrus A, Ranzani O, Menendez R, Torres A.

PLoS One. 2017 Apr 6;12(4):e0175171. doi: 10.1371/journal.pone.0175171. eCollection 2017.

15.

Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.

Cillóniz C, Torres A, Manzardo C, Gabarrús A, Ambrosioni J, Salazar A, García F, Ceccato A, Mensa J, de la Bella Casa JP, Moreno A, Miró JM.

Chest. 2017 Aug;152(2):295-303. doi: 10.1016/j.chest.2017.03.007. Epub 2017 Mar 14.

PMID:
28302496
16.

Seasonality of pathogens causing community-acquired pneumonia.

Cilloniz C, Ewig S, Gabarrus A, Ferrer M, Puig de la Bella Casa J, Mensa J, Torres A.

Respirology. 2017 May;22(4):778-785. doi: 10.1111/resp.12978. Epub 2017 Jan 17.

PMID:
28093834
17.

Invasive Disease vs Urinary Antigen-Confirmed Pneumococcal Community-Acquired Pneumonia.

Ceccato A, Torres A, Cilloniz C, Amaro R, Gabarrus A, Polverino E, Prina E, Garcia-Vidal C, Muñoz-Conejero E, Mendez C, Cifuentes I, Puig de la Bella Casa J, Menendez R, Niederman MS.

Chest. 2017 Jun;151(6):1311-1319. doi: 10.1016/j.chest.2017.01.005. Epub 2017 Jan 16.

PMID:
28093269
18.

Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.

Fernández-Barat L, Ferrer M, De Rosa F, Gabarrús A, Esperatti M, Terraneo S, Rinaudo M, Li Bassi G, Torres A.

J Infect. 2017 Feb;74(2):142-152. doi: 10.1016/j.jinf.2016.11.008. Epub 2016 Nov 16.

PMID:
27865895
19.

The clinical value of biomarkers in respiratory complications in hematopoietic SCT.

Lucena CM, Rovira M, Gabarrús A, Filella X, Martínez C, Domingo R, Torres A, Agustí C.

Bone Marrow Transplant. 2017 Mar;52(3):415-422. doi: 10.1038/bmt.2016.280. Epub 2016 Oct 31.

PMID:
27797370
20.

Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia.

Amaro R, Liapikou A, Cilloniz C, Gabarrus A, Marco F, Sellares J, Polverino E, Garau J, Ferrer M, Musher DM, Torres A.

Eur Respir J. 2016 Sep;48(3):797-807. doi: 10.1183/13993003.00039-2016. Epub 2016 May 12.

21.

Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumonia.

Liapikou A, Cillóniz C, Gabarrús A, Amaro R, De la Bellacasa JP, Mensa J, Sánchez M, Niederman M, Torres A.

Eur Respir J. 2016 Jul;48(1):257-61. doi: 10.1183/13993003.00191-2016. Epub 2016 Apr 21. No abstract available.

22.

Community-Acquired Pneumonia Due to Multidrug- and Non-Multidrug-Resistant Pseudomonas aeruginosa.

Cillóniz C, Gabarrús A, Ferrer M, Puig de la Bellacasa J, Rinaudo M, Mensa J, Niederman MS, Torres A.

Chest. 2016 Aug;150(2):415-25. doi: 10.1016/j.chest.2016.03.042. Epub 2016 Apr 7.

PMID:
27060725
23.

Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.

Guerrero M, Crisafulli E, Liapikou A, Huerta A, Gabarrús A, Chetta A, Soler N, Torres A.

PLoS One. 2016 Mar 4;11(3):e0150737. doi: 10.1371/journal.pone.0150737. eCollection 2016.

24.

Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome.

Ferrer M, Difrancesco LF, Liapikou A, Rinaudo M, Carbonara M, Li Bassi G, Gabarrus A, Torres A.

Crit Care. 2015 Dec 23;19:450. doi: 10.1186/s13054-015-1165-5.

25.

Bacteraemia in outpatients with community-acquired pneumonia.

Cillóniz C, Gabarrús A, Almirall J, Amaro R, Rinaudo M, Travierso C, Niederman M, Torres A.

Eur Respir J. 2016 Feb;47(2):654-7. doi: 10.1183/13993003.01308-2015. Epub 2015 Nov 5. No abstract available.

26.

Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids.

Crisafulli E, Torres A, Huerta A, Guerrero M, Gabarrús A, Gimeno A, Martinez R, Soler N, Fernández L, Wedzicha JA, Menéndez R.

COPD. 2016;13(1):82-92. doi: 10.3109/15412555.2015.1057276. Epub 2015 Oct 9.

PMID:
26451913
27.

Sensitivity, Specificity, and Positivity Predictors of the Pneumococcal Urinary Antigen Test in Community-Acquired Pneumonia.

Molinos L, Zalacain R, Menéndez R, Reyes S, Capelastegui A, Cillóniz C, Rajas O, Borderías L, Martín-Villasclaras JJ, Bello S, Alfageme I, Rodríguez de Castro F, Rello J, Ruiz-Manzano J, Gabarrús A, Musher DM, Torres A.

Ann Am Thorac Soc. 2015 Oct;12(10):1482-9. doi: 10.1513/AnnalsATS.201505-304OC.

PMID:
26288389
28.

Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients.

Polverino E, Cilloniz C, Menendez R, Gabarrus A, Rosales-Mayor E, Alcaraz V, Terraneo S, Puig de la Bella Casa J, Mensa J, Ferrer M, Torres A.

J Infect. 2015 Jul;71(1):28-36. doi: 10.1016/j.jinf.2015.03.009. Epub 2015 Apr 14.

PMID:
25882347
29.

The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.

Cilloniz C, Albert RK, Liapikou A, Gabarrus A, Rangel E, Bello S, Marco F, Mensa J, Torres A.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1265-72. doi: 10.1164/rccm.201502-0212OC.

PMID:
25807239
30.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, Gabarrús A, Sellarés J, Restrepo MI, Anzueto A, Niederman MS, Agustí C.

JAMA. 2015 Feb 17;313(7):677-86. doi: 10.1001/jama.2015.88.

31.

Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis.

Torres A, Cillóniz C, Ferrer M, Gabarrús A, Polverino E, Villegas S, Marco F, Mensa J, Menéndez R, Niederman M.

Eur Respir J. 2015 May;45(5):1353-63. doi: 10.1183/09031936.00152514. Epub 2015 Jan 22.

32.

Severity and outcomes of community acquired pneumonia in asthmatic patients.

Terraneo S, Polverino E, Cilloniz C, Amaro R, Vennera Mdel C, Gabarrus A, Montull B, Moreno E, Menendez R, Centanni S, Torres A.

Respir Med. 2014 Nov;108(11):1713-22. doi: 10.1016/j.rmed.2014.09.001. Epub 2014 Sep 16.

33.

Pulmonary complications in hematopoietic SCT: a prospective study.

Lucena CM, Torres A, Rovira M, Marcos MA, de la Bellacasa JP, Sánchez M, Domingo R, Gabarrus A, Mensa J, Agustí C.

Bone Marrow Transplant. 2014 Oct;49(10):1293-9. doi: 10.1038/bmt.2014.151. Epub 2014 Jul 21.

PMID:
25046219
34.

Gravity predominates over ventilatory pattern in the prevention of ventilator-associated pneumonia.

Li Bassi G, Marti JD, Saucedo L, Rigol M, Roca I, Cabanas M, Muñoz L, Ranzani OT, Giunta V, Luque N, Esperatti M, Gabarrus A, Fernandez L, Rinaudo M, Ferrer M, Ramirez J, Vila J, Torres A.

Crit Care Med. 2014 Sep;42(9):e620-7. doi: 10.1097/CCM.0000000000000487.

PMID:
24979484
35.

Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome.

Cilloniz C, Torres A, Polverino E, Gabarrus A, Amaro R, Moreno E, Villegas S, Ortega M, Mensa J, Marcos MA, Moreno A, Miro JM.

Eur Respir J. 2014 Jun;43(6):1698-708. doi: 10.1183/09031936.00155813. Epub 2014 Feb 13.

36.

Impact of age and comorbidity on cause and outcome in community-acquired pneumonia.

Cillóniz C, Polverino E, Ewig S, Aliberti S, Gabarrús A, Menéndez R, Mensa J, Blasi F, Torres A.

Chest. 2013 Sep;144(3):999-1007. doi: 10.1378/chest.13-0062.

PMID:
23670047
37.

Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.

Polverino E, Cillóniz C, Dambrava P, Gabarrús A, Ferrer M, Agustí C, Prina E, Montull B, Menendez R, Niederman MS, Torres A.

Respirology. 2013 Feb;18(2):263-71. doi: 10.1111/resp.12013.

PMID:
23134361
38.

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia.

Cillóniz C, Ewig S, Menéndez R, Ferrer M, Polverino E, Reyes S, Gabarrús A, Marcos MA, Cordoba J, Mensa J, Torres A.

J Infect. 2012 Sep;65(3):223-30. doi: 10.1016/j.jinf.2012.04.009. Epub 2012 Apr 26.

PMID:
22543245
39.

Reliability of a self-administered diary of symptoms for assessing the evolution of acute bronchitis.

Moragas A, Llor C, Gabarrús A, Miravitlles M.

Arch Bronconeumol. 2012 Jul;48(7):261-2. doi: 10.1016/j.arbres.2012.02.006. Epub 2012 Apr 6. English, Spanish. No abstract available.

40.

Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy.

Fernández-Barat L, Li Bassi G, Ferrer M, Bosch A, Calvo M, Vila J, Gabarrús A, Martínez-Olondris P, Rigol M, Esperatti M, Luque N, Torres A.

FEMS Immunol Med Microbiol. 2012 Jul;65(2):309-17. doi: 10.1111/j.1574-695X.2012.00961.x. Epub 2012 Apr 23.

41.

Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease.

Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrús A, Torres A, Miravitlles M.

Respiration. 2012;84(1):17-26. doi: 10.1159/000335467. Epub 2012 Feb 11.

42.

Community-acquired pneumonia in outpatients: aetiology and outcomes.

Cillóniz C, Ewig S, Polverino E, Marcos MA, Prina E, Sellares J, Ferrer M, Ortega M, Gabarrús A, Mensa J, Torres A.

Eur Respir J. 2012 Oct;40(4):931-8. Epub 2012 Jan 20.

43.

Effects of duty cycle and positive end-expiratory pressure on mucus clearance during mechanical ventilation*.

Li Bassi G, Saucedo L, Marti JD, Rigol M, Esperatti M, Luque N, Ferrer M, Gabarrus A, Fernandez L, Kolobow T, Torres A.

Crit Care Med. 2012 Mar;40(3):895-902. doi: 10.1097/CCM.0b013e318236efb5.

PMID:
22080638
44.

Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes.

Cillóniz C, Ewig S, Polverino E, Muñoz-Almagro C, Marco F, Gabarrús A, Menéndez R, Mensa J, Torres A.

Clin Microbiol Infect. 2012 Nov;18(11):1134-42. doi: 10.1111/j.1469-0691.2011.03692.x. Epub 2011 Nov 1.

45.

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis.

Cillóniz C, Ewig S, Ferrer M, Polverino E, Gabarrús A, Puig de la Bellacasa J, Mensa J, Torres A.

Crit Care. 2011;15(5):R209. doi: 10.1186/cc10444. Epub 2011 Sep 14.

46.

Microbial aetiology of community-acquired pneumonia and its relation to severity.

Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, Mensa J, Torres A.

Thorax. 2011 Apr;66(4):340-6. doi: 10.1136/thx.2010.143982. Epub 2011 Jan 21.

PMID:
21257985
47.

Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic.

Riquelme R, Torres A, Rioseco ML, Ewig S, Cillóniz C, Riquelme M, Inzunza C, Polverino E, Gomez Y, Marcos MA, Contreras C, Gabarrús A, Fasce R.

Eur Respir J. 2011 Jul;38(1):106-11. doi: 10.1183/09031936.00125910. Epub 2010 Nov 25.

48.

Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure.

Bayes-Genis A, Vazquez R, Puig T, Fernandez-Palomeque C, Fabregat J, Bardají A, Pascual-Figal D, Ordoñez-Llanos J, Valdes M, Gabarrús A, Pavon R, Pastor L, Gonzalez Juanatey JR, Almendral J, Fiol M, Nieto V, Macaya C, Cinca J, Bayes de Luna A; MUSIC Study Group.

Eur J Heart Fail. 2007 Aug;9(8):802-7. Epub 2007 Jun 13.

Supplemental Content

Loading ...
Support Center